Tralokinumab

Generic name: Tralokinumab
Brand names: Adbry
Dosage form: subcutaneous solution (ldrm 150mg/mL)
Drug class: Interleukin inhibitors

Usage of Tralokinumab

Tralokinumab is used in adults to treat moderate-to-severe eczema (atopic dermatitis) that is not well controlled with topical medicines (applied to the skin), or in people who cannot use topical medicines. tralokinumab can be used with or without topical steroids.

Tralokinumab may also be used for purposes not listed in this medication guide.

Tralokinumab side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Tralokinumab may cause serious side effects. Call your doctor at once if you have:

worsening eye problems, eye pain, or changes in your vision.

Common side effects of tralokinumab may include:

pain, bruising, swelling, or irritation where the medicine was injected;

eye and eyelid redness, swelling, and itching; or

high count of a certain type of white blood cells (eosinophilia).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Tralokinumab

You should not use tralokinumab if you are allergic to it.

Tell your doctor if you have:

eye problems;

a parasitic infection; or

if you are scheduled to receive a vaccine.

Tell your doctor if you are pregnant or breastfeeding.

Relate drugs

How to use Tralokinumab

Usual Adult Dose for Atopic Dermatitis:

Initial dose: 600 mg suBCutaneously onceMaintenance dose (after initial dose): 300 mg subcutaneously every other week-After 16 weeks of therapy: 300 mg subcutaneously every 4 weeks may be considered for patients below 100 kg who achieved clear or almost clear skinComments:-Treatment should be initiated by health care providers experienced in the diagnosis and treatment of atopic dermatitis.-Before starting this drug, all age-appropriate vaccinations (as recommended by current immunization guidelines) should be completed.-This drug can be used with or without topical corticosteroids.-Topical calcineurin inhibitors may be used, but should be reserved for problem areas (face, neck, intertriginous, and genital).Use: For the treatment of moderate to severe atopic dermatitis when the disease is not adequately controlled with topical prescription agents or when such agents are not advisable

Warnings

Use only as directed. Tell your doctor if you use other medicines or have other medical conditions or allergies.

What other drugs will affect Tralokinumab

Other drugs may affect tralokinumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.